NetworkNewsBreaks – Neutra Corp. (NTRR) Targets
Post# of 70
Neutra Corp. (OTCQB: NTRR), an early-stage research and development company, is aiming to participate in the hemp-based CBD market through its recent strategic acquisition of Vivis Corp. A recent article discussing the interview reads, “The U.S. cannabis- and hemp-derived CBD market is expected to reach $20 billion by 2024, driven at a compound annual growth rate of 49%, according to leading cannabis researchers BDS Analytics and Arcview Market Research (http://nnw.fm/9e3wS). The report predicts that the majority of CBD product sales will soon occur in general retail stores, rather than in cannabis dispensaries. . . . Neutra Corp.’s previously announced acquisition of Vivis Corp., an emerging retail brand of hemp-based health and nutritional products, is a natural fit for the company. All Vivis CBD products are third-party tested and certified, assuring the consumer that its hemp-derived CBD products are contaminant free and of a consistently high purity (http://nnw.fm/yMs0O).”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer